HK1222584A1 - 包含細菌混合物的組合物及用於降低酒精的影響的方法，該細菌混合物包含片球菌和乳酸菌 - Google Patents
包含細菌混合物的組合物及用於降低酒精的影響的方法，該細菌混合物包含片球菌和乳酸菌Info
- Publication number
- HK1222584A1 HK1222584A1 HK16110906.4A HK16110906A HK1222584A1 HK 1222584 A1 HK1222584 A1 HK 1222584A1 HK 16110906 A HK16110906 A HK 16110906A HK 1222584 A1 HK1222584 A1 HK 1222584A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pedoiococcus
- lactobacillus
- bacteria
- alcohols
- decreasing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 2
- 241000894006 Bacteria Species 0.000 title 1
- 241000186660 Lactobacillus Species 0.000 title 1
- 150000001298 alcohols Chemical class 0.000 title 1
- 230000003247 decreasing effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 229940039696 lactobacillus Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361821974P | 2013-05-10 | 2013-05-10 | |
| PCT/US2014/037704 WO2014183117A1 (en) | 2013-05-10 | 2014-05-12 | Compositions comprising a mixture of bacteria comprising pedoiococcus and lactobacillus an methods for decreasing the effects of alcohols |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1222584A1 true HK1222584A1 (zh) | 2017-07-07 |
Family
ID=50980375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16110906.4A HK1222584A1 (zh) | 2013-05-10 | 2016-09-14 | 包含細菌混合物的組合物及用於降低酒精的影響的方法，該細菌混合物包含片球菌和乳酸菌 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10130664B2 (zh) |
| EP (1) | EP2994149A1 (zh) |
| JP (1) | JP6452258B2 (zh) |
| KR (1) | KR20160013069A (zh) |
| CN (1) | CN106456679A (zh) |
| AU (2) | AU2014262427B2 (zh) |
| CA (1) | CA2911947A1 (zh) |
| HK (1) | HK1222584A1 (zh) |
| RU (1) | RU2671221C2 (zh) |
| WO (1) | WO2014183117A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015259359A1 (en) * | 2014-05-12 | 2016-11-17 | BiOWiSH Technologies, Inc. | Compositions and methods for improving human health and nutrition |
| KR101853603B1 (ko) | 2017-05-18 | 2018-05-02 | 주식회사 쎌바이오텍 | 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물 |
| CA3096300A1 (en) | 2018-05-29 | 2019-12-05 | BiOWiSH Technologies, Inc. | Compositions and methods for improving survivability of aquatic animals |
| CN109350629B (zh) * | 2018-08-09 | 2021-06-01 | 新乡医学院 | 一种用于治疗酒精戒断综合征的益生菌复合制剂及其制备方法 |
| CN115919907A (zh) | 2021-08-31 | 2023-04-07 | E·施约林 | 一种用于治疗和/或预防食物和/或酒精中毒的组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ334294A (en) | 1996-08-22 | 2000-02-28 | Bioteknologisk Inst | Metabolically engineered lactic acid bacteria and means for providing same |
| US6953574B2 (en) * | 2002-06-21 | 2005-10-11 | Technology Commercialization, Inc. | Method for producing a fermented hydrolyzed medium containing microorganisms |
| JP4817323B2 (ja) * | 2004-07-29 | 2011-11-16 | 京都府 | 植物病害防除剤および防除方法 |
| FR2881751B1 (fr) * | 2005-02-07 | 2007-04-27 | Virbac Sa Sa | Compositions comprenant des micro-organismes deshydrates, leurs procedes de preparation, et leurs utilisations |
| KR100661032B1 (ko) * | 2005-04-19 | 2006-12-22 | 주식회사한국야쿠르트 | 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물 |
| US20060263385A1 (en) * | 2005-05-17 | 2006-11-23 | Fran Gare | Composition to relieve side effects of alcohol intoxication |
| JP5413819B2 (ja) | 2008-02-08 | 2014-02-12 | 国立大学法人広島大学 | 肝機能改善剤およびその製造用ツール、ならびにこれらの利用 |
| IT1392101B1 (it) | 2008-12-12 | 2012-02-09 | Zuccari Societa A Responsabilita Limitata In Breve Zuccari S R L | Composizione comprendente isoflavoni |
| US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
| US9161957B2 (en) | 2012-08-03 | 2015-10-20 | Life Well Lived, Llc | Compositions and methods for reducing blood alcohol content |
| EP2914275A1 (en) | 2012-10-30 | 2015-09-09 | Nestec S.A. | Compositions comprising microparticles and probiotics to deliver a synergistic immune effect |
| CN102934809B (zh) | 2012-12-10 | 2014-04-30 | 济南大学 | 益生菌发酵中药制剂制备的组合物及其制备方法和应用 |
-
2014
- 2014-05-12 CA CA2911947A patent/CA2911947A1/en not_active Abandoned
- 2014-05-12 EP EP14732049.3A patent/EP2994149A1/en not_active Withdrawn
- 2014-05-12 AU AU2014262427A patent/AU2014262427B2/en not_active Ceased
- 2014-05-12 KR KR1020157035087A patent/KR20160013069A/ko unknown
- 2014-05-12 WO PCT/US2014/037704 patent/WO2014183117A1/en active Application Filing
- 2014-05-12 RU RU2015152826A patent/RU2671221C2/ru not_active IP Right Cessation
- 2014-05-12 JP JP2016513140A patent/JP6452258B2/ja not_active Expired - Fee Related
- 2014-05-12 US US14/275,683 patent/US10130664B2/en not_active Expired - Fee Related
- 2014-05-12 CN CN201480026365.XA patent/CN106456679A/zh active Pending
-
2016
- 2016-09-14 HK HK16110906.4A patent/HK1222584A1/zh unknown
-
2019
- 2019-03-08 AU AU2019201637A patent/AU2019201637A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2671221C2 (ru) | 2018-10-30 |
| US10130664B2 (en) | 2018-11-20 |
| RU2015152826A (ru) | 2017-06-20 |
| AU2014262427B2 (en) | 2018-12-13 |
| JP2016521287A (ja) | 2016-07-21 |
| US20140335187A1 (en) | 2014-11-13 |
| WO2014183117A1 (en) | 2014-11-13 |
| CA2911947A1 (en) | 2014-11-13 |
| AU2014262427A1 (en) | 2015-11-26 |
| AU2019201637A1 (en) | 2019-04-11 |
| KR20160013069A (ko) | 2016-02-03 |
| EP2994149A1 (en) | 2016-03-16 |
| CN106456679A (zh) | 2017-02-22 |
| JP6452258B2 (ja) | 2019-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211866A1 (zh) | 抗氧化劑組合物及其使用方法 | |
| GB2521022B (en) | Compositions and methods | |
| IL265876A (en) | Preparations that include 15-ohepa and methods of using them | |
| HK1214171A1 (zh) | 賽尼克韋羅組合物及其製備和使用方法 | |
| IL286759A (en) | Therapeutic methods and preparations | |
| EP2953474A4 (en) | COMPOSITIONS AND METHODS | |
| EP2964235A4 (en) | ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE | |
| GB201308072D0 (en) | Compositions and methods | |
| HK1221416A1 (zh) | 氧雜雙環庚烷和氧雜雙環庚烯的配製品 | |
| ZA201509262B (en) | Tuberculosis compositions and methods of using the same | |
| HK1222584A1 (zh) | 包含細菌混合物的組合物及用於降低酒精的影響的方法，該細菌混合物包含片球菌和乳酸菌 | |
| GB201305813D0 (en) | Compositions and methods | |
| PL3013855T3 (pl) | Zmutowany czynnik viii – kompozycje i sposoby wytwarzania | |
| HK1220374A1 (zh) | 用於治療碳氧血紅蛋白血症的組合物和方法 | |
| EP2964610A4 (en) | VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF | |
| GB201300628D0 (en) | Compositions comprising 15-OHEPA and methods of using the same | |
| GB201319917D0 (en) | Accelerator Compositions and Methods | |
| GB201322617D0 (en) | Methods and compositions | |
| GB201319255D0 (en) | Therapeutic compositions and methods | |
| GB201312393D0 (en) | Compositions and Methods |